Sunil Verma: Discussing the transformation in Oncology and future of Cancer care with John Whyte
Sunil Verma shared on X:
“Today, I had the pleasure of discussing the transformation in Oncology and future of Cancer care with John Whyte, CMO at WebMD as part of his Cancer in Context series. I look forward to sharing our in-depth discussion on convergence of science and tech with the Oncology community!”
Source: Sunil Verma/X
Sunil Verma, MD, MSEd, FRCPC, is the Senior Vice Precident, Global Head of Oncology Franchise at AstraZeneca. He was also an Associate Professor at the University of Toronto and Medical Oncologist and Research Lead for the Division of Medical Oncology at Sunnybrook Odette Cancer Centre.
Dr. Verma’s research focuses on breast cancer therapies. As principal investigator for multiple breast cancer trials, including Phase III studies, his research has been published in journals like the New England Journal of Medicine, The Lancet, Journal of Clinical Oncology, and Cancer.
Dr. John Whyte is the Chief Medical Officer of WebMD. He serves on the Board of Trustees at Morehouse School of Medicine and is a member of the Board of Directors at the Alliance for Aging Research.
His mission is to empower and educate consumers, patients, and healthcare professionals with trusted, evidence-based, and user-friendly information to help them live healthier lives.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023